1. Comment to Jatoi et al. report

   • Romano Demicheli
   • Gianni Bonadonna
   • Michael Baum

   Commentary Pages: 1 - 2

2. Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab

   • Noël Dybdal
   • Grazyna Leiberman
   • Michael F. Press

   Report Pages: 3 - 11

3. Obesity and Cardiovascular Risk Factors in Younger Breast Cancer Survivors: The Cancer and Menopause Study (CAMS)

   • Dena R. Herman
   • Patricia A. Ganz
   • Gail A. Greendale

   Report Pages: 13 - 23

4. Adjuvant Ovarian Suppression Versus Chemotherapy for Premenopausal, Hormone-responsive Breast Cancer: Quality of Life and Efficacy Tradeoffs

   • Elena B. Elkin
   • Milton C. Weinstein
   • Jane C. Weeks

   Report Pages: 25 - 34

5. Systemic Effects of Surgery: Quantitative Analysis of Circulating Basic Fibroblast Growth Factor (bFGF), Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor Beta (TGF-β) in Patients with Breast Cancer Who Underwent Limited or Extended Surgery

   • G. Curigliano
   • J. Y. Petit
   • A. Goldhirsch

   Report Pages: 35 - 40

6. The Influence of Marital Status on the Stage at Diagnosis, Treatment, and Survival of Older Women with Breast Cancer

   • Cynthia Osborne
   • Glenn V. Ostir
   • James S. Goodwin

   Report Pages: 41 - 47

7. The Comparison of Two Different Physiotherapy Methods in Treatment of Lymphedema after Breast Surgery

   • Karadіbak Dіdem
   • Yurdalan S. Ufuk
   • Arican Zümre

   Report Pages: 49 - 54

8. The Pilot Trial on Intraoperative Radiotherapy with Electrons (ELIOT): Update on the Results

   • Alberto Luini
   • Roberto Orecchia
   • Umberto Veronesi

   Report Pages: 55 - 59

9. The Effect of Exemestane on the Lipidemic Profile of Postmenopausal Early Breast Cancer Patients: Preliminary Results of the TEAM Greek Sub-study

   • C. Markopoulos
   • A. Polychronis
   • H. Gogas

   Report Pages: 61 - 66

10. Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

    • Bhuvaneswari Ramaswamy
    • Steven P Povoski
    • Charles L. Shapiro

    Clinical trial Pages: 67 - 74

11. Changes on Bone Mineral Density after Adjuvant Treatment in Women with Non-metastatic Breast Cancer

    • Luz-Milva Rodríguez-Rodríguez
    • Eva-María Rodríguez-Rodríguez
    • Norberto Batista

    Report Pages: 75 - 83

12. Management of Nonpalpable Breast Lesions in a Modern Functional Breast Unit

    • Vittorio Altomare
    • Gabriella Guerriero
    • Carla Rabitti

    Report Pages: 85 - 89

13. Primary Malignancy after Primary Female Breast Cancer in the South of the Netherlands, 1972–2001

    • I. Soerjomataram
    • W. J. Louwman
    • J. W. W. Coebergh

    Report Pages: 91 - 95